BioWorld MedTech

Feb. 25, 2011

Deals roundup: Thermo Fisher in plan to sell diagnostic labs for $940M

Thermo Fisher Scientific (Waltham, Massachusetts) reported that it has signed definitive agreements to sell Athena Diagnostics (Worcester, Massachusetts) to Quest Diagnostics (Madison, New Jersey) for $740 million. (Medical Device Daily) Read More

Cook launches EchoTip ProCore, new histology needle for EUS

International report: Mazor's PIPE dreams up $6.3M in new capital funds for company

RFID Hospial Smart Room uses real-time patient data

Agreements/contracts: Masimo to license Pulse for Royal Fornia monitors

MDD's food for med-tech thought

New ventures: Biolase Technology forms new imaging business unit

Clarification

Product Briefs

HIT roundup: Lumedx launches Enabling EHR suite for meaningful use

People in the News

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 13, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 13, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

LINC01116 has prognostic value in lung cancer, study shows

BioWorld MedTech

Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...

SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

BioWorld Science

Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...